The animal parasiticides market consists of pharmaceuticals used to treat and prevent parasite infestations in livestock and companion animals. Parasitic infections in animals include both external parasites such as fleas, ticks, mites and lice and internal parasites including roundworms, tapeworms, heartworms, protozoa and coccidia. Left untreated, parasitic infestations can cause immense discomfort to infected animals as well as economic loss to farmers and breeders. Animal parasiticides play a crucial role in maintaining the health and wellbeing of animals across the world.

Market Dynamics:

The global animal parasiticides market is driven by rising meat consumption worldwide, increasing demand for poultry production and the growing focus on animal welfare. Mass livestock production has increased the risk of parasite transmission, boosting demand for preventive and therapeutic parasiticides. Rising pet ownership in developing nations is another key driver as parasites pose a significant health threat to companion animals. However, stringent regulations pertaining to the use of parasiticides in food producing animals and growing preference for alternative therapies hamper market growth. On the other hand, development of novel parasiticides with improved efficacy and safety offers lucrative opportunities in the coming years.

For instance, according to the World Animal Foundation Organization, in August 2023, there were around 34.4 billion chickens in the world as of June 2023. The U.S. leads the world in chicken production with 9.22 billion chickens per year. There are four chickens for every person on earth.

Key Features of the Study:

• This report provides an in-depth analysis of the global animal parasiticides market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global Animal Parasiticides Market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Venkys India Ltd., Inovio Pharmaceuticals, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global animal parasiticides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal parasiticides market

Animal Parasiticides Market Detailed Segmentation:

• By Product Type:
  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides
• By Animal Type:
  • Companion
    • Dogs
    • Cats
    • Others (Rabbits, Ferrets, etc.)
  • Livestock
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Others (Donkey, Goats, etc.)
• By Distribution Channel:
  • Veterinary Hospitals & Clinics
  • Pharmacies
  • E-commerce
  • Others (pet stores, etc.)
• By Region: 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Merck Animal Health
  • Bayer
  • Vetoquinol
  • Ceva Santé Animale
  • Neogen Corporation
  • Dechra Pharmaceuticals
  • Heska Corporation
  • Norbrook Laboratories
  • Idexx Laboratories